Difficulty: Medium
Average Score: 68%
Practice
Common pathogens in the sputum of CF patients are:
Correct answer
A
Rationale
In cystic fibrosis (CF) patients, common pathogens found in sputum play a significant role in disease progression. Pseudomonas aeruginosa is a key pathogen in CF due to its ability to form biofilms, leading to chronic infections and increased morbidity. This bacterium is often resistant to multiple antibiotics, complicating treatment.
Staphylococcus aureus is another common pathogen in CF, but it is more prevalent in younger patients and tends to decrease in adulthood. Staphylococcus epidermidis is a less common pathogen in CF and is usually considered a contaminant rather than a pathogen. Burkholderia cepacia complex is a serious pathogen in CF, associated with poor clinical outcomes and increased mortality.
Educationally, understanding the specific pathogens involved in CF is crucial for nurses caring for pediatric patients with this condition. Recognizing the characteristics of each pathogen allows for appropriate treatment interventions, infection control measures, and patient education strategies to prevent exacerbations and improve outcomes. The emphasis on Pseudomonas aeruginosa in CF highlights its significance in disease management and the challenges it poses in clinical practice.
Staphylococcus aureus is another common pathogen in CF, but it is more prevalent in younger patients and tends to decrease in adulthood. Staphylococcus epidermidis is a less common pathogen in CF and is usually considered a contaminant rather than a pathogen. Burkholderia cepacia complex is a serious pathogen in CF, associated with poor clinical outcomes and increased mortality.
Educationally, understanding the specific pathogens involved in CF is crucial for nurses caring for pediatric patients with this condition. Recognizing the characteristics of each pathogen allows for appropriate treatment interventions, infection control measures, and patient education strategies to prevent exacerbations and improve outcomes. The emphasis on Pseudomonas aeruginosa in CF highlights its significance in disease management and the challenges it poses in clinical practice.